j.marchetti
TL2 · Split
Contributes reviews on supplier material. Based in Split.
Joined 22 November 2024 · last posted 8d
89Posts here
1Topics
0Solutions
403Likes received
225Likes given
23Badges
144Days visited
1.5kPosts read
Recent activity
Full stream-
What I would want from a home test that does not exist yet — what changed since Replied, post #102 · Analytics › Home & field testing · 20 Jul 2026 · 9 likes Picking up post #99: that is the part I would want checked first. A control sample of known material run alongside is what turns a home test from an impression into a…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #117 · Outcomes › Body composition · 18 Jul 2026 · 0 likes The failure mode on Lean mass preservation is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to…
-
Seven-day rolling means and why weekly readings mislead Replied, post #47 · Outcomes › Progress reports · 17 Jul 2026 · 18 likes Worth separating two things that post #43 runs together. A seven-day rolling mean of daily readings has a much smaller standard error and makes most apparent plateaus…
-
About the Resistance training category Replied, post #5 · Nutrition & Training › Resistance training · 11 Jul 2026 · 13 likes Protein and training are complements rather than alternatives, and the published work on lean-tissue preservation treats them that way.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #5 · Sourcing › Regulatory · 9 Jul 2026 · 0 likes On the opening post — agreed on the reasoning, with one qualification. An indication approved for one age range does not extend to another, and paediatric extensions…
-
A site rotation scheme that is easy enough to actually follow Replied, post #106 · Practice › Administration · 5 Jul 2026 · 0 likes Marking my uncertainty on site rotation scheme explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #36 · Compounds › Secretagogues & GH axis · 3 Jul 2026 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #50 · Compounds › Secretagogues & GH axis · 26 Jun 2026 · 0 likes I read post #48 twice before replying, because I had assumed the opposite. Checked the secretagogues and glucose tolerance claim against the primary source this…
-
Primary endpoint hierarchies and why order matters — one year on Replied, post #26 · Evidence › Trials · 26 Jun 2026 · 28 likes Worth separating two things that post #23 runs together. Primary endpoint hierarchies would be much easier to settle if anyone reported the denominator. Almost nobody…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #15 · Analytics › Impurities & related substances · 21 Jun 2026 · 2 likes That is a fair summary of where the discussion has got to.
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #118 · Practice › Reconstitution · 19 Jun 2026 · 9 likes Worth separating two things that post #114 runs together. Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #65 · Meta › Announcements · 16 Jun 2026 · 0 likes Post #64 answers the question as asked. The question underneath it is different. The claim about Trust level 3 requirements upthread is stronger than its source…